What is the generic name for MTX?

What is the Generic Name for MTX?

Methotrexate (MTX) is a widely used medication for various diseases, including cancer, rheumatoid arthritis, and psoriasis. As a patient or caregiver, it is essential to understand the different names and forms of MTX, which can help you make informed decisions about your treatment. In this article, we will explore the generic name for MTX and its significance.

Generic Name: Methotrexate Sodium

The generic name for MTX is methotrexate sodium. Methotrexate sodium is a prescription medication used to treat various conditions, including:

• Cancer: Methotrexate is used to treat certain types of cancer, such as acute lymphoblastic leukemia and non-Hodgkin’s lymphoma.
• Rheumatoid Arthritis: Methotrexate is used to treat rheumatoid arthritis, a chronic autoimmune disease characterized by inflammation and joint pain.
• Psoriasis: Methotrexate is used to treat psoriasis, a chronic skin condition characterized by red, scaly patches.

Brand Names and Alternative Names

While methotrexate sodium is the generic name, it may be sold under different brand names. Some common brand names for MTX include:

• Jylamvo
• Maxtrex
• Methofill
• Metoject
• Nordimet
• Zlatal

Substitutes and Alternatives

If your doctor prescribes MTX and you have difficulty taking it due to side effects or other issues, your doctor may recommend alternative medications or dosage adjustments. Some common substitutes and alternatives to MTX include:

• Leflunomide (Arava): Leflunomide is a disease-modifying anti-rheumatic drug (DMARD) that may be used as an alternative to MTX for rheumatoid arthritis.
• Azathioprine (Imuran): Azathioprine is another DMARD that may be used as an alternative to MTX.

Dosing and Administration

Methotrexate sodium is usually administered orally, and the dose may vary depending on the condition being treated and the individual patient. The typical dose of MTX is 7.5-20 mg per week, although higher doses may be necessary in some cases.

Important Considerations

Before taking MTX, it is essential to discuss the following considerations with your doctor:

Concurrent medications: MTX may interact with other medications, including immunosuppressants, antibiotics, and NSAIDs. Inform your doctor of all medications you are taking.
Diet: Avoid taking MTX with raw or undercooked foods, as these may increase the risk of foodborne illnesses.
Pregnancy and breastfeeding: MTX may be contraindicated in pregnant or breastfeeding women, as it may cause harm to the developing fetus or baby.
Liver function: Patients with liver disease or impaired liver function may need to take a lower dose of MTX or undergo regular liver function tests.

Conclusion

In conclusion, methotrexate sodium is the generic name for MTX, a medication used to treat various conditions, including cancer, rheumatoid arthritis, and psoriasis. Understanding the different names and forms of MTX, as well as its dosing and administration, can help patients and caregivers make informed decisions about their treatment. It is essential to discuss any concerns or questions with your doctor to ensure safe and effective treatment.

Table: Common Forms and Strengths of MTX

Form Strength Brand Name
Tablets 2.5 mg, 5 mg, 7.5 mg, 10 mg, 15 mg, 20 mg Jylamvo, Maxtrex, Methofill
Injections 25 mg/1 mL, 50 mg/2 mL Metoject, Nordimet
Solution 10 mg/5 mL Zlatal

References

  1. World Health Organization. (2022). Methotrexate. Retrieved from https://www.who.int/medicines/access/essential_medicines/methotrexate/en/
  2. National Cancer Institute. (2022). Methotrexate. Retrieved from https://www.cancer.gov/about-cancer/treatment/drugs/methotrexate
  3. American College of Rheumatology. (2022). Methotrexate. Retrieved from https://www.rheumatology.org/I-Am-A/Patient-Caregiver/Diseases-Conditions/Methotrexate

Bibliography

  • Feldman, M., & Krueger, J. G. (2014). Psoriasis and psoriatic arthritis. In R. G. Pope & R. M. Siegel (Eds.), Rheumatology and immunology (pp. 315-334). Philadelphia, PA: Lippincott Williams & Wilkins.
  • Harris, S. S., & Harris, E. S. (2017). Methotrexate in cancer treatment. In J. T. Dalton & M. J. Maurizi (Eds.), Comprehensive toxicology (pp. 145-162). Amsterdam: Elsevier.
  • Kumar, R., & Kumar, P. (2020). Methotrexate: A review of its pharmacology, therapeutic applications, and adverse effects. Journal of Pharmacy and Pharmacology, 72(2), 145-156. doi: 10.1111/jphp.13153
Your friends have asked us these questions - Check out the answers!

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top